Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DMOG46
|
|||
| Drug Name |
APG-157
|
|||
| Indication | Oral cavity squamous cell carcinoma [ICD-11: 2B6E.0; ICD-9: 199] | Phase 2 | [1] | |
| Company |
Aveta Biomics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05312710) Phase 2 Study to Evaluate the Safety and Efficacy of APG-157 as Neoadjuvant/Induction Therapy for Patients With Head and Neck Squamous Cell Cancer (HNSCC) of the Oral Cavity and/or Oropharynx. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.